Point72 (Difc) LTD Gossamer Bio, Inc. Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
A detailed history of Point72 (Difc) LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 12,700 shares of GOSS stock, worth $13,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,700Holding current value
$13,335% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
160MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$19.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$19 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$10.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.46 Million7.27% of portfolio
-
Silverarc Capital Management, LLC6.32MShares$6.64 Million1.69% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $98.7M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...